798 related articles for article (PubMed ID: 32023560)
1. Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.
Yamada M; Okada S; Oda H; Nakajima Y; C Bastie C; Kasai Y; Osaki A; Shimoda Y; Shibusawa R; Uehara R; Saito T; Ozawa A; Yamada E
Endocr J; 2020 May; 67(5):531-536. PubMed ID: 32023560
[TBL] [Abstract][Full Text] [Related]
2. HBA1C AND MEAN GLUCOSE DERIVED FROM SHORT-TERM CONTINUOUS GLUCOSE MONITORING ASSESSMENT DO NOT CORRELATE IN PATIENTS WITH HBA1C >8.
Yamada E; Okada S; Nakajima Y; Bastie CC; Vatish M; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Okamura T; Ozawa A; Yamada M
Endocr Pract; 2017 Jan; 23(1):10-16. PubMed ID: 27631849
[TBL] [Abstract][Full Text] [Related]
3. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes.
Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C
J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102
[TBL] [Abstract][Full Text] [Related]
4. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
5. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
[TBL] [Abstract][Full Text] [Related]
6. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
[TBL] [Abstract][Full Text] [Related]
7. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
8. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
9. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
Vigersky RA; McMahon C
Diabetes Technol Ther; 2019 Feb; 21(2):81-85. PubMed ID: 30575414
[TBL] [Abstract][Full Text] [Related]
10. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
[TBL] [Abstract][Full Text] [Related]
11. The Calculation of the Glucose Management Indicator Is Influenced by the Continuous Glucose Monitoring System and Patient Race.
Angellotti E; Muppavarapu S; Siegel RD; Pittas AG
Diabetes Technol Ther; 2020 Sep; 22(9):651-657. PubMed ID: 31821016
[No Abstract] [Full Text] [Related]
12. Use of Flash Glucose Monitoring and Glycemic Control in Patients with Type 2 Diabetes Mellitus Not Treated with an Intensive Insulin Regimen: 1-Year Real-Life Retrospective Cohort Study.
Al Hayek AA; Al Dawish MA
Adv Ther; 2023 Jun; 40(6):2855-2868. PubMed ID: 37133646
[TBL] [Abstract][Full Text] [Related]
13. Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study.
Bailey TS; Zisser HC; Garg SK
Diabetes Technol Ther; 2007 Jun; 9(3):203-10. PubMed ID: 17561790
[TBL] [Abstract][Full Text] [Related]
14. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial.
Ajjan RA; Jackson N; Thomson SA
Diab Vasc Dis Res; 2019 Jul; 16(4):385-395. PubMed ID: 31271312
[TBL] [Abstract][Full Text] [Related]
15. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
[TBL] [Abstract][Full Text] [Related]
16. Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes.
Slattery D; Choudhary P
Diabetes Technol Ther; 2017 May; 19(S2):S55-S61. PubMed ID: 28541131
[TBL] [Abstract][Full Text] [Related]
17. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
Martens T; Beck RW; Bailey R; Ruedy KJ; Calhoun P; Peters AL; Pop-Busui R; Philis-Tsimikas A; Bao S; Umpierrez G; Davis G; Kruger D; Bhargava A; Young L; McGill JB; Aleppo G; Nguyen QT; Orozco I; Biggs W; Lucas KJ; Polonsky WH; Buse JB; Price D; Bergenstal RM;
JAMA; 2021 Jun; 325(22):2262-2272. PubMed ID: 34077499
[TBL] [Abstract][Full Text] [Related]
18. Associations between continuous glucose monitoring-derived metrics and HbA1c in patients with type 2 diabetes mellitus.
Kurozumi A; Okada Y; Mita T; Wakasugi S; Katakami N; Yoshii H; Kanda K; Nishida K; Mine S; Tanaka Y; Gosho M; Shimomura I; Watada H
Diabetes Res Clin Pract; 2022 Apr; 186():109836. PubMed ID: 35314256
[TBL] [Abstract][Full Text] [Related]
19. Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study.
Gilbert TR; Noar A; Blalock O; Polonsky WH
Diabetes Technol Ther; 2021 Mar; 23(S1):S35-S39. PubMed ID: 33470882
[No Abstract] [Full Text] [Related]
20. The Associations of Mean Glucose and Time in Range from Continuous Glucose Monitoring with HbA1c in Adults with Type 2 Diabetes.
Selvin E; Wang D; Rooney MR; Echouffo-Tcheugui J; Fang M; Zeger S; Sartini J; Tang O; Coresh J; Aurora RN; Punjabi NM
Diabetes Technol Ther; 2023 Jan; 25(1):86-90. PubMed ID: 36108310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
